Helius Medical Technologies, Inc. (HSDT)
USD 0.4
(-2.44%)
USD 0.4
(-2.44%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 12.48 Million USD | -19.33% |
| 2022 | 15.08 Million USD | -17.88% |
| 2021 | 18.36 Million USD | 25.29% |
| 2020 | 14.65 Million USD | -40.52% |
| 2019 | 24.64 Million USD | -9.23% |
| 2018 | 27.15 Million USD | 18.82% |
| 2017 | 22.85 Million USD | 120.29% |
| 2016 | 10.37 Million USD | 17.03% |
| 2015 | 8.86 Million USD | 730.58% |
| 2014 | 1.06 Million USD | -87.47% |
| 2013 | 8.51 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.42 Million USD | 49.91% |
| 2024 Q2 | 3.32 Million USD | -2.75% |
| 2023 Q2 | 3.29 Million USD | -13.37% |
| 2023 Q1 | 3.79 Million USD | 35.63% |
| 2023 Q4 | 2.28 Million USD | -22.64% |
| 2023 Q3 | 2.95 Million USD | -10.36% |
| 2023 FY | 12.16 Million USD | -19.33% |
| 2022 Q3 | 4.19 Million USD | 21.09% |
| 2022 Q1 | 4.63 Million USD | 9.43% |
| 2022 Q4 | 2.8 Million USD | -33.17% |
| 2022 FY | 15.08 Million USD | -17.88% |
| 2022 Q2 | 3.46 Million USD | -25.25% |
| 2021 Q3 | 4.39 Million USD | -28.75% |
| 2021 FY | 18.36 Million USD | 25.29% |
| 2021 Q1 | 3.57 Million USD | 19.32% |
| 2021 Q2 | 6.17 Million USD | 72.83% |
| 2021 Q4 | 4.23 Million USD | -3.75% |
| 2020 Q4 | 2.99 Million USD | -20.62% |
| 2020 Q1 | 4.1 Million USD | -24.89% |
| 2020 Q2 | 3.79 Million USD | -7.72% |
| 2020 Q3 | 3.76 Million USD | -0.58% |
| 2020 FY | 14.65 Million USD | -40.52% |
| 2019 Q1 | 7.26 Million USD | 26.49% |
| 2019 FY | 24.64 Million USD | -9.23% |
| 2019 Q4 | 5.46 Million USD | -5.66% |
| 2019 Q3 | 5.79 Million USD | -5.28% |
| 2019 Q2 | 6.12 Million USD | -15.73% |
| 2018 Q3 | 4.89 Million USD | -58.58% |
| 2018 FY | 27.15 Million USD | 18.82% |
| 2018 Q2 | 11.8 Million USD | 150.31% |
| 2018 Q1 | 4.71 Million USD | -19.64% |
| 2018 Q4 | 5.74 Million USD | 17.4% |
| 2017 FY | 22.85 Million USD | 120.29% |
| 2017 Q1 | 5.03 Million USD | 156.29% |
| 2017 Q2 | 5.98 Million USD | 18.8% |
| 2017 Q3 | 5.97 Million USD | -0.17% |
| 2017 Q4 | 5.87 Million USD | -1.68% |
| 2016 Q2 | 2.1 Million USD | -27.83% |
| 2016 FY | 10.37 Million USD | 17.03% |
| 2016 Q1 | 2.91 Million USD | 2.63% |
| 2016 Q4 | 1.96 Million USD | -42.08% |
| 2016 Q3 | 3.39 Million USD | 61.16% |
| 2015 Q1 | -4.02 Million USD | -197.81% |
| 2015 Q4 | 2.84 Million USD | 167.58% |
| 2015 FY | 8.86 Million USD | 730.58% |
| 2015 Q3 | 1.06 Million USD | -62.55% |
| 2015 Q2 | 2.83 Million USD | 170.43% |
| 2014 Q2 | 1.56 Million USD | 159.68% |
| 2014 Q1 | 602.42 Thousand USD | 80.58% |
| 2014 Q3 | 2.76 Million USD | 76.9% |
| 2014 Q4 | 4.11 Million USD | 48.7% |
| 2014 FY | 1.06 Million USD | -87.47% |
| 2013 Q2 | 63.98 Thousand USD | 0.0% |
| 2013 FY | 8.51 Million USD | 0.0% |
| 2013 Q3 | 67.28 Thousand USD | 5.15% |
| 2013 Q4 | 333.59 Thousand USD | 395.84% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -11.27% |
| Cerus Corporation | 143.15 Million USD | 91.276% |
| OrthoPediatrics Corp. | 137.01 Million USD | 90.885% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -9.93% |
| Talis Biomedical Corporation | 67.18 Million USD | 81.411% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 49.936% |
| Inogen, Inc. | 236.08 Million USD | 94.71% |
| Spectral AI, Inc. | 20.86 Million USD | 40.141% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 77.697% |
| CVRx, Inc. | 76.14 Million USD | 83.598% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -253.997% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.129% |
| Venus Concept Inc. | 80.47 Million USD | 84.481% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 77.926% |
| Bioventus Inc. | 409.91 Million USD | 96.953% |
| BrainsWay Ltd. | 28.01 Million USD | 55.425% |
| Envoy Medical, Inc. | 17.89 Million USD | 30.221% |
| electroCore, Inc. | 32.03 Million USD | 61.01% |
| IceCure Medical Ltd | 16.87 Million USD | 25.995% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 70.567% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 29.173% |
| MaxCyte, Inc. | 84.84 Million USD | 85.28% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -0.622% |
| Nexalin Technology, Inc. | 5.78 Million USD | -116.022% |
| PAVmed Inc | 64.82 Million USD | 80.735% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 75.549% |
| RxSight, Inc. | 103.85 Million USD | 87.974% |
| Sight Sciences, Inc. | 126.44 Million USD | 90.123% |
| SI-BONE, Inc. | 156.35 Million USD | 92.012% |
| TELA Bio, Inc. | 84.18 Million USD | 85.165% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 82.173% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 93.859% |
| LivaNova PLC | 843.54 Million USD | 98.519% |
| 908 Devices Inc. | 68.08 Million USD | 81.655% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 97.417% |
| Nemaura Medical Inc. | 7.13 Million USD | -74.945% |
| NeuroPace, Inc. | 75.29 Million USD | 83.413% |
| LENSAR, Inc. | 33.33 Million USD | 62.536% |
| Apyx Medical Corporation | 51.01 Million USD | 75.52% |
| Cutera, Inc. | 197.72 Million USD | 93.684% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 49.603% |
| BioSig Technologies, Inc. | 28.53 Million USD | 56.225% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 93.477% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 65.366% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 98.507% |
| Axonics, Inc. | 270.2 Million USD | 95.378% |
| Outset Medical, Inc. | 198.77 Million USD | 93.717% |
| IRIDEX Corporation | 31.81 Million USD | 60.744% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 93.07% |
| IRadimed Corporation | 30.12 Million USD | 58.54% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -46.378% |
| INVO Bioscience, Inc. | 7.85 Million USD | -59.029% |
| Telesis Bio, Inc. | 63.48 Million USD | 80.329% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 87.315% |
| Varex Imaging Corporation | 224.8 Million USD | 94.444% |
| Quipt Home Medical Corp. | 148.66 Million USD | 91.599% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -6.534% |
| Pulmonx Corporation | 112.68 Million USD | 88.917% |
| Dynatronics Corporation | 9.9 Million USD | -26.049% |
| Modular Medical, Inc. | 17.52 Million USD | 28.752% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 38.133% |
| Semler Scientific, Inc. | 38.94 Million USD | 67.931% |
| InMode Ltd. | 215.68 Million USD | 94.209% |
| Bruker Corporation | 1.07 Billion USD | 98.84% |
| Cytosorbents Corporation | 48.33 Million USD | 74.163% |
| DexCom, Inc. | 1.69 Billion USD | 99.262% |
| Align Technology, Inc. | 2.07 Billion USD | 99.399% |
| Viveve Medical, Inc. | 22.17 Million USD | 43.675% |
| ZimVie Inc. | 275.12 Million USD | 95.461% |
| Movano Inc. | 29.69 Million USD | 57.935% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 90.902% |
| Nexalin Technology, Inc. | 5.78 Million USD | -116.022% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -253.997% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 97.922% |
| Profound Medical Corp. | 33.6 Million USD | 62.834% |
| Insulet Corporation | 939.9 Million USD | 98.671% |
| enVVeno Medical Corporation | 25.23 Million USD | 50.515% |
| Surmodics, Inc. | 98.69 Million USD | 87.346% |
| iCAD, Inc. | 22.22 Million USD | 43.807% |
| Nuwellis, Inc. | 22.61 Million USD | 44.771% |
| Biotricity, Inc. | 17.18 Million USD | 27.324% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 97.199% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1.723% |
| InspireMD, Inc. | 22.95 Million USD | 45.582% |
| PAVmed Inc. | 64.82 Million USD | 80.735% |
| BIOLASE, Inc. | 34.66 Million USD | 63.968% |
| Beyond Air, Inc. | 61.7 Million USD | 79.759% |
| FONAR Corporation | 28.6 Million USD | 56.339% |
| AxoGen, Inc. | 149.33 Million USD | 91.637% |
| Vivani Medical, Inc. | 26.96 Million USD | 53.684% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 92.948% |
| Inari Medical, Inc. | 448.59 Million USD | 97.216% |
| UFP Technologies, Inc. | 58.08 Million USD | 78.5% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -153.45% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -97.664% |
| Tenon Medical, Inc. | 16.96 Million USD | 26.397% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -68.93% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 71.682% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.841% |
| Sintx Technologies, Inc. | 15.2 Million USD | 17.841% |
| NanoVibronix, Inc. | 4.97 Million USD | -151.136% |
| Quanterix Corporation | 118.1 Million USD | 89.425% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -6.534% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 13.523% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 96.819% |
| TransMedics Group, Inc. | 182.82 Million USD | 93.169% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 55.5% |
| NeuroMetrix, Inc. | 11.09 Million USD | -12.524% |
| Hyperfine, Inc. | 52.87 Million USD | 76.379% |
| Establishment Labs Holdings Inc. | 172 Million USD | 92.739% |
| Biomerica, Inc. | 6.97 Million USD | -78.977% |
| Bone Biologics Corporation | 9.42 Million USD | -32.463% |
| AVITA Medical, Inc. | 80.77 Million USD | 84.539% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -21.121% |
| Silk Road Medical, Inc | 186.35 Million USD | 93.298% |